🔎 Trials Near Me

Hjem › Mage-tarmstromale tumorer › Massachusetts

Kliniske studier for Mage-tarmstromale tumorer i Massachusetts

9 studier for Mage-tarmstromale tumorer søker deltakere på steder i Massachusetts.

Byer i Massachusetts

Offisiell studietekst (engelsk)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Dana-Farber Cancer Institute - Oncology Department, Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Boston
  • GSK Investigational Site, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07218926

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

  • Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07406633

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

  • University of Massachusetts Worcester, Worcester
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT05957367

Integrated Cancer Repository for Cancer Research

  • Holyoke Medical Center, Holyoke
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

PH 2 Pemigatinib in SDH-deficient GIST

  • Dana Farber Cancer Institute, Boston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT07434843

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

  • Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06630234

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

  • Massachusetts General Hospital, Boston
  • Harvard University, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. feb. 2026 · NCT06655246

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.